Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation

Journal of Clinical Oncology

Volumn 14, Issue 11, 1996, Pages 2901-2907

  Coppin, C M ^a   Gospodarowicz, M K ^a   James, K ^a   Tannock, I F ^a   Zee, B ^a   Carson, J ^a   Pater, J ^a   Sullivan, L D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0029851252     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.11.2901     Document Type: Article

References (51)

1. Slack NH, Bross IDJ, Prout GR Jr: Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol 9:393-405, 1977
2. Miller LS: Bladder cancer: Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39:973-980, 1977
3. Bloom HJG, Hendry WF, Wallace DM, et al: Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54:136-151, 1982
4. Sell A, Jakobsen A, Nerstrom B, et al: Treatment of advanced bladder cancer category T2 T3 and T4a. Scand J Urol Nephrol S138:193-201, 1991
5. Mameghan H, Fisher RJ, Watt WH, et al: The management of invasive transitional cell carcinoma of the bladder. Cancer 69:2771-2778, 1992
6. Duncan W, Quilty PM: The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage x-ray therapy. Radiother Oncol 7:299-310, 1986
7. Quilty PM, Duncan W, Chisholm GD, et al: Results of surgery following radical radiotherapy for invasive bladder cancer. Br J Urol 58:396-405, 1986
8. Paulson DF: Critical review of radical cystectomy and indicators of prognosis. Semin Urol 11:205-213, 1993
9. Fossa SD, Ous S, Berner A: Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy. Br J Urol 67:54-60, 1991
10. Herr HW: Staging invasive bladder tumors. J Surg Oncol 51:217-220, 1992
11. Pollack A, Zagars GK, Swanson DA: Muscle-invasive bladder cancer treated with external beam radiotherapy: Prognostic factors. Int J Radiat Oncol Biol Phys 30:267-277, 1994
12. Cole CJ, Pollack A, Zagars GK, et al: Local control of muscle-invasive bladder cancer: Preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys 32:331-340, 1995
13. Anderson P, Dische S: Local tumor control and the subsequent incidence of distant metastatic disease. Int J Radiat Oncol Biol Phys 7:1645-1648, 1981
14. Prout GR, Griffin PP, Shipley WU: Bladder carcinoma as a systemic disease. Cancer 43:2532-2539, 1979
15. Yagoda A, Watson RC, Gonzalez-Vitale JC, et al: Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. Cancer Treat Rep 60:917-923, 1976
16. Scher HI, Norton L: Chemotherapy for urothelial tract malignancies: Breaking the deadlock. Semin Surg Oncol 8:316-341, 1992
17. Loehrer PS Sr, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol 10:1066-1073, 1992
18. Soloway MS, Ikard M, Ford K: Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer. Cancer 47:476-480, 1981
19. Pearson BS, Raghavan D: First-line intravenous cisplatin for deeply invasive bladder cancer: Update on 70 cases. Br J Urol 57:690-693, 1985
20. Wallace DMA, Raghavan D, Kelly KA, et al: Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 67:608-615, 1991
21. Martinez-Pineiro JA, Martin MG, Arocena F, et al: Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: A prospective randomized phase III study. J Urol 153:964-973, 1995
22. Einstein AB, Shipley W, Coombs J, et al: Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities. Urology 23:110-117, 1984
23. Studer UE, Bacci M, Biedermann C, et al: Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial. J Urol 152:81-84, 1994
24. Dewit L: Combined treatment of radiation and cis-diamminedichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13:403-426, 1987
25. Dewit L, Oussoren Y, Bartelink H, et al: The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation. Radiother Oncol 16:121-128, 1989
26. Douple EB, Richmond RC: Platinum complexes as radiosensitizers of hypoxic mammalian cells. Br J Cancer 37:98-102, 1978 (suppl 3)
27. Kyriazis AP, Yagoda A, Kereiakes JG, et al: Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II in human bladder transitional cell carcinomas grown in nude mice. Cancer 52:452-457, 1983
28. Soloway MS, Morris CR, Sudderth B: Radiation therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer. Int J Radiat Oncol Biol Phys 5:1355-1360, 1979
29. Reimer RR, Gahbauer R, Bukowski RM, et al: Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: A pilot study. Cancer Treat Rep 65:219-222, 1981
30. Soloway MS, Ikard M, Scheinberg M, et al: Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: A preliminary report. J Urol 128:1031-1033, 1982
31. Jakse G, Frommhold H, Zur Nedden D: Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder. Cancer 55:1659-1664, 1985
32. Coppin C, Brown E: Concurrent cisplatin with radiation for locally advanced bladder cancer: A pilot study suggesting improved survival. Proc Am Soc Clin Oncol 5:99, 1986 (abstr 382)
33. Shipley WU, Prout GR Jr, Einstein AB, et al: Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258:931-935, 1987
34. Tester W, Porter A, Asbell S, et al: Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25:783-790, 1993
35. Dunst J, Sauer R, Schrott KM, et al: Organ-sparing treatment of advanced bladder cancer: A 10-year experience. Int J Radiat Oncol Biol Phys 30:261-266, 1994
36. Coppin C, Gospodarowicz M: The NCI-Canada trial of concurrent cisplatin and radiotherapy for muscle invasive bladder cancer. Prog Clin Biol Res 353:75-83, 1990
37. Tannock IF: Endpoints of clinical trials in invasive bladder cancer. Semin Oncol 17:619-627, 1990
38. Hargis JB, Anderson JR, Propert KJ, et al: Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: A CALGB study. Cancer Chemother Pharmacol 30:291-296, 1992
39. Skinner DG, Lieskovsky G: Contemporary cystectomy with pelvic node dissecton compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 131:1069-1072, 1984
40. Logothetis CJ, Samuels ML, Ogden S, et al: Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases. J Urol 134:460-464, 1985
41. Meyers FJ, Palmer JM, Freiha FS, et al: The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: A Northern California Oncology Group study. J Urol 134:1118-1121, 1985
42. Scher HI, Yagoda A, Herr HW, et al: Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J Urol 139:470-474, 1988
43. Gospodarowicz MK, Rider WD, Keen CW, et al: Bladder cancer: Long-term follow-up results of patients treated with radical radiation. Clin Oncol 3:155-161, 1991
44. Greven KM, Spera JA, Solin LJ, et al: Local recurrence after cystectomy alone for bladder carcinoma. Cancer 69:2767-2770, 1992
45. Gospodarowicz MK, Warde PR: A critical review of the role of definitive radiation therapy in bladder cancer. Semin Urol 11:214-226, 1993
46. Ghersi D, Stewart LA, Parmar MKB, et al: Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: A meta-analysis of individual patient data from randomized clinical trials. Br J Urol 75:206-213, 1995
47. Wajsman Z, Marino R, Parsons J, et al: Bladder-sparing approach in the treatment of invasive bladder cancer. Semin Urol 8:210-215, 1990
48. Kaufman DS, Shipley WU, Griffin PP, et al: Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 329:1377-1382, 1993
49. Heaney JA, Caplan R, Tester WJ, et al: Bladder preservation in patients treated by a neoadjuvant combined modality program for invasive bladder cancer. J Urol 151:453A, 1994 (abstr)
50. Rintala E, Hannisdahl E, Fossa SD, et al: Neoadjuvant chemotherapy in bladder cancer: A randomized study. Scand J Urol Nephrol 27:355-362, 1993
51. Hall RR, Parmar MKB: Randomized intercontinental trial of locoregional therapy with or without neoadjuvant chemotherapy. Prog Clin Biol Res 353:105-109, 1990